Drugs / DURAPATITE
DURAPATITE
also known as
hydroxyapatite · Ossopan · Ossopan 200 · Ossopan 800 · Tribasic calcium phosphate · WIN 40350
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07177053 Comparator | Nov 2025 → Nov 2026 expected | — | Dubai Health | Not yet recruiting | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DURAPATITE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2218916 ↗ |
| Known as | hydroxyapatite | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07177053 ↗ |
| Known as | Ossopan | ChEMBL registry synonym — accepted as the source's own label CHEMBL2218916 ↗ |
| Known as | Ossopan 200 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2218916 ↗ |
| Known as | Ossopan 800 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2218916 ↗ |
| Known as | Tribasic calcium phosphate | ChEMBL registry synonym — accepted as the source's own label CHEMBL2218916 ↗ |
| Known as | WIN 40350 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2218916 ↗ |
| Modality | Other / unclassified | “non fluoridated hydroxyapatite tooth paste (KAREX KINDER tooth paste)” NCT07177053 ↗ |